AI assistant
Sending…
ProPhase Labs, Inc. — Director's Dealing 2017
Dec 18, 2017
34999_dirs_2017-12-18_e7328657-c7e9-4873-9f34-ad3c9f22d965.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2017-12-14
Reporting Person: Karkus Ted William (Director, CEO & CHAIRMAN, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-14 | Common Stock, par value $0.005 | M | 600000 | $1.00 | Acquired | 2909638 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-14 | Employee Stock Option (right to buy) | $1.00 | M | 600000 | Disposed | 2017-12-14 | Common Stock (600000) | Direct |
Footnotes
F1: These employee stock options vested in annual installments of 100,000, 100,000, 100,000 and 300,000 shares on December 14, 2011, 2012, 2013 and 2014, respectively.
More from ProPhase Labs, Inc.
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Jan 27
Regulatory Filings
2026
Jan 23
Delisting Announcement
2026
Jan 23
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 2